Crescent Biopharma Reports Second Quarter 2026 Financial Results and Recent Business Highlights

Go back to Crescent Biopharma Reports Second Quarter 2026 Financial Results and Recent Business Highlights
(NASDAQ: CBIO) Delayed: 20.88 +0.48 (2.35%)
Previous Close $20.40    52 Week High $4.57 
Open $20.09    52 Week Low $0.62 
Day High $21.53    P/E N/A 
Day Low $20.09    EPS $0.00 
Volume 239,696